25-Nov-2024 3:00 PM CST - Business Wire Compass Pathways to Participate in December Investor Conferences $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that members of the executive management team will participate in the following investor conferences in addition to hosting investor meetings: 7th Annual Evercore ISI HealthCONx Conference: Fireside chat at 10:25am ET on December 3, 2024 Piper Sandler 36th Annual Healthcare Conference: Fireside ch
31-Oct-2024 5:30 AM CST - Business Wire Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS) (Compass), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, today reported its financial results for the third quarter 2024 and an update on recent business progress. Ensuring the success of our lead COMP360 program is our absolute priority. We remain confident that COMP360 can be an effective therapy for patients with serious mental illness and our focus on deliveri
24-Oct-2024 5:30 AM CST - Business Wire Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024 $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the third quarter 2024 ending September 30, 2024, and provide an update on recent business developments, on October 31, 2024. The management team will host a conference call at 8:00 am ET (12:00 pm UK) on October 31, 2024. To access the call, please register in adva
24-Sep-2024 3:43 AM CST - Business Wire Compass Pathways nimmt am Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit teil Compass Pathways plc (Nasdaq: CMPS) (Compass), ein Biotechnologieunternehmen, das sich fr einen schnelleren Zugang zu evidenzbasierten Innovationen im Bereich der psychischen Gesundheit einsetzt, gab heute bekannt, dass Fhrungskrfte des Managementteams am 26. September 2024 um 13:20 Uhr ET an einem Kamingesprch auf dem Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit teilnehmen werden. Eine Live-Audio-bertragung des Chats wird auf der
24-Sep-2024 3:43 AM CST - Business Wire Riassunto: Compass Pathways parteciper al summit Psychedelics and Novel Mechanisms in Neuropsychiatry di Cowen Compass Pathways plc (Nasdaq: CMPS) ("Compass"), un'azienda di biotecnologia che si dedica a promuovere l'accesso alle innovazioni basate sulle evidenze nell'ambito della salute mentale, ha annunciato oggi che i dirigenti del team manageriale parteciperanno a una "chiacchierata informale" in occasione del Psychedelics and Novel Mechanisms in Neuropsychiatry Summit di Cowen il 26 settembre 2024 alle 13:20 ET. Un webcast audio in diretta della chat sar disponi
24-Sep-2024 3:42 AM CST - Business Wire Resumen: Compass Pathways participar en Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit Compass Pathways plc (Nasdaq: CMPS) (Compass), una empresa de biotecnologa dedicada a acelerar el acceso a la innovacin basada en la evidencia en salud mental, ha anunciado hoy que ejecutivos del equipo directivo participarn en una charla informal en Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit el 26 de septiembre de 2024 a la 1:20 pm ET. En la pgina de eventos del sitio web de Compass se ofrecer una retransmisin de audio en di
24-Sep-2024 3:42 AM CST - Business Wire Samenvatting: Compass Pathways aanwezig op Cowen-top over psychedelica en nieuwe mechanismen in de neuropsychiatrie Compass Pathways plc (Nasdaq: CMPS) ("Compass"), een biotechnologiebedrijf dat zich toelegt op het versnellen van de toegang tot wetenschappelijk onderbouwde innovatie in de geestelijke gezondheidszorg, kondigde vandaag aan dat leidinggevenden van het managementteam zullen deelnemen aan een fireside chat op de Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit op 26 september 2024 om 13.20 uur ET. Een live audiowebcast van de chat is beschikbaa
23-Sep-2024 6:00 AM CST - Business Wire Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit Compass Pathways plc (Nasdaq: CMPS) (Compass), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, announced today that executives from the management team will be participating in a fireside chat at the Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit on September 26, 2024 at 1:20pm ET. A live audio webcast of the chat will be available on the Events page of the Compass website and will b
25-Nov-2024 3:00 PM CST - Business Wire Compass Pathways to Participate in December Investor Conferences $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that members of the executive management team will participate in the following investor conferences in addition to hosting investor meetings: 7th Annual Evercore ISI HealthCONx Conference: Fireside chat at 10:25am ET on December 3, 2024 Piper Sandler 36th Annual Healthcare Conference: Fireside ch
31-Oct-2024 5:30 AM CST - Business Wire Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS) (Compass), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, today reported its financial results for the third quarter 2024 and an update on recent business progress. Ensuring the success of our lead COMP360 program is our absolute priority. We remain confident that COMP360 can be an effective therapy for patients with serious mental illness and our focus on deliveri
24-Oct-2024 5:30 AM CST - Business Wire Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024 $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the third quarter 2024 ending September 30, 2024, and provide an update on recent business developments, on October 31, 2024. The management team will host a conference call at 8:00 am ET (12:00 pm UK) on October 31, 2024. To access the call, please register in adva
24-Sep-2024 3:43 AM CST - Business Wire Compass Pathways nimmt am Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit teil Compass Pathways plc (Nasdaq: CMPS) (Compass), ein Biotechnologieunternehmen, das sich fr einen schnelleren Zugang zu evidenzbasierten Innovationen im Bereich der psychischen Gesundheit einsetzt, gab heute bekannt, dass Fhrungskrfte des Managementteams am 26. September 2024 um 13:20 Uhr ET an einem Kamingesprch auf dem Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit teilnehmen werden. Eine Live-Audio-bertragung des Chats wird auf der
24-Sep-2024 3:43 AM CST - Business Wire Riassunto: Compass Pathways parteciper al summit Psychedelics and Novel Mechanisms in Neuropsychiatry di Cowen Compass Pathways plc (Nasdaq: CMPS) ("Compass"), un'azienda di biotecnologia che si dedica a promuovere l'accesso alle innovazioni basate sulle evidenze nell'ambito della salute mentale, ha annunciato oggi che i dirigenti del team manageriale parteciperanno a una "chiacchierata informale" in occasione del Psychedelics and Novel Mechanisms in Neuropsychiatry Summit di Cowen il 26 settembre 2024 alle 13:20 ET. Un webcast audio in diretta della chat sar disponi
24-Sep-2024 3:42 AM CST - Business Wire Resumen: Compass Pathways participar en Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit Compass Pathways plc (Nasdaq: CMPS) (Compass), una empresa de biotecnologa dedicada a acelerar el acceso a la innovacin basada en la evidencia en salud mental, ha anunciado hoy que ejecutivos del equipo directivo participarn en una charla informal en Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit el 26 de septiembre de 2024 a la 1:20 pm ET. En la pgina de eventos del sitio web de Compass se ofrecer una retransmisin de audio en di
24-Sep-2024 3:42 AM CST - Business Wire Samenvatting: Compass Pathways aanwezig op Cowen-top over psychedelica en nieuwe mechanismen in de neuropsychiatrie Compass Pathways plc (Nasdaq: CMPS) ("Compass"), een biotechnologiebedrijf dat zich toelegt op het versnellen van de toegang tot wetenschappelijk onderbouwde innovatie in de geestelijke gezondheidszorg, kondigde vandaag aan dat leidinggevenden van het managementteam zullen deelnemen aan een fireside chat op de Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit op 26 september 2024 om 13.20 uur ET. Een live audiowebcast van de chat is beschikbaa
23-Sep-2024 6:00 AM CST - Business Wire Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit Compass Pathways plc (Nasdaq: CMPS) (Compass), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, announced today that executives from the management team will be participating in a fireside chat at the Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit on September 26, 2024 at 1:20pm ET. A live audio webcast of the chat will be available on the Events page of the Compass website and will b
